(Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 90.60%-74.99K | 3.24%-3.04M | -80.46%-1.04M | -51.87%-463.82K | 4.03%-732.15K | 46.54%-797.73K | -3.14M | -578.22K | 64.82%-305.42K | -47.46%-762.9K |
Net income from continuing operations | -44.01%-1.91M | -26.42%-7.68M | -99.27%-2.93M | -41.05%-1.85M | 12.43%-1.57M | 11.35%-1.32M | ---6.07M | ---1.47M | -24.76%-1.31M | 76.86%-1.8M |
Operating gains losses | ---- | 246.10%61.99K | ---7.63K | --0 | --0 | --69.61K | ---42.43K | ---- | ---- | ---- |
Depreciation and amortization | 39.23%561.44K | 46.41%1.94M | 25.25%499.63K | 56.08%594.48K | 33.51%445.77K | 88.87%403.25K | --1.33M | --398.92K | 104.54%380.88K | 125.23%333.89K |
Remuneration paid in stock | -32.48%69.9K | 166.17%769K | 581.80%435.89K | 14.63%131.7K | 19.79%97.88K | 264.71%103.53K | --288.91K | --63.93K | 283.54%114.89K | -98.82%81.71K |
Deferred tax | ---- | ---199.45K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Other non cashItems | 144.50%524.7K | 100.90%1.44M | 166.11%554.43K | 137.99%463.86K | -0.32%204.43K | 100.39%214.6K | --715.44K | --208.35K | 46.13%194.91K | 151.96%205.09K |
Change In working capital | 354.22%674.72K | -2.66%626.31K | 129.32%602K | -38.00%195.15K | -77.20%94.56K | 23.86%-265.41K | --643.42K | --262.52K | 288.52%314.76K | 271.16%414.71K |
-Change in receivables | 17.75%-113.8K | 199.08%82.75K | 168.82%19.43K | -908.77%-143.49K | 2,596.04%345.17K | -54.89%-138.37K | ---83.52K | --7.23K | -182.81%-14.22K | -72.87%12.8K |
-Change in inventory | ---39.48K | --89.04K | --293.69K | --0 | ---204.65K | --0 | --0 | --0 | --0 | ---- |
-Change in prepaid assets | 513.17%150.15K | -2,859.33%-1.45M | -436.57%-302.12K | -462.30%-445.39K | -676.48%-727.49K | 113.18%24.49K | ---49.02K | --89.76K | 66.58%-79.21K | 147.73%126.2K |
-Change in payables and accrued expense | 448.68%744.22K | 140.92%1.73M | 273.31%419.3K | 104.84%812.98K | 147.54%706.81K | -172.05%-213.44K | --716.28K | --112.32K | 885.62%396.88K | 3.51%285.53K |
-Change in other current liabilities | ---44.11K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
-Change in other working capital | -135.93%-22.25K | 200.55%179.38K | 222.71%171.7K | -355.86%-28.95K | -157.39%-25.28K | 1,142.38%61.91K | --59.68K | --53.21K | -10.31%11.32K | -118.50%-9.82K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 90.60%-74.99K | 3.24%-3.04M | -80.46%-1.04M | -51.87%-463.82K | 4.03%-732.15K | 46.54%-797.73K | ---3.14M | ---578.22K | 64.82%-305.42K | -47.46%-762.9K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -55.63%-173.86K | -337.65%-8.5M | 135.70%750.56K | -1,229.87%-5.6M | -493.80%-3.54M | 91.01%-111.72K | -1.94M | 318.44K | 28.62%-420.93K | -498.51%-596.12K |
Capital expenditure reported | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---50.93K |
Net PPE purchase and sale | 93.07%-156.02K | 86.78%-275.91K | 534.96%2.3M | 81.57%-77.58K | 53.98%-250.89K | -280.61%-2.25M | ---2.09M | ---529.58K | 28.62%-420.93K | -19.71%-545.18K |
Net business purchase and sale | ---- | ---8.33M | ---111.77K | ---5.5M | ---- | ---- | --0 | --0 | --0 | ---- |
Net other investing changes | -100.83%-17.84K | -28.37%103.99K | ---1.44M | ---20.21K | ---573.87K | --2.14M | --145.18K | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -55.63%-173.86K | -337.65%-8.5M | 135.70%750.56K | -1,229.87%-5.6M | -493.80%-3.54M | 91.01%-111.72K | ---1.94M | --318.44K | 28.62%-420.93K | -498.51%-596.12K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -77.45%164.7K | 113.84%11.16M | -76.07%107.09K | 995.93%5.55M | 911.21%4.77M | -84.95%730.4K | 5.22M | 447.61K | 281.51%506.22K | -433.36%-588.59K |
Net issuance payments of debt | -66.60%209.36K | 770.89%6.81M | -94.01%30.56K | 1,130.64%5.59M | 199.87%565.95K | 63.10%626.86K | --782.04K | --510.35K | 264.92%454.02K | -107.82%-566.67K |
Net common stock issuance | -143.13%-44.66K | -2.54%4.32M | 268.38%57.68K | --0 | 19,090.37%4.16M | -97.68%103.54K | --4.44M | ---34.25K | 759.99%23.71K | -113.51%-21.92K |
Net other financing activities | ---- | --25K | --18.86K | ---39.54K | ---- | ---- | ---- | ---- | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -77.45%164.7K | 113.84%11.16M | -76.07%107.09K | 995.93%5.55M | 911.21%4.77M | -84.95%730.4K | --5.22M | --447.61K | 281.51%506.22K | -433.36%-588.59K |
Net cash flow | ||||||||||
Beginning cash position | -146.61%-116.4K | 123.99%249.74K | -3.56%59.71K | 103.34%573.49K | -96.83%70.69K | 123.99%249.74K | --111.5K | --61.91K | -85.44%282.03K | -2.31%2.23M |
Current changes in cash | 53.00%-84.15K | -371.87%-375.84K | -198.93%-185.81K | -133.41%-513.79K | 125.82%502.81K | -108.45%-179.05K | --138.24K | --187.83K | 87.33%-220.12K | -307.36%-1.95M |
Effect of exchange rate changes | --5.25K | --9.7K | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
End cash Position | -376.29%-195.3K | -146.61%-116.4K | -146.61%-116.4K | -3.56%59.71K | 103.34%573.49K | -96.83%70.69K | --249.74K | --249.74K | -69.10%61.91K | -85.44%282.03K |
Free cash from | 92.42%-231.01K | 36.60%-3.31M | 411.14%1.26M | 25.46%-541.4K | 27.67%-983.04K | -11.45%-3.05M | ---5.23M | ---404.96K | 50.18%-726.34K | -39.71%-1.36M |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data